Submissions
Submission Preparation Checklist
All submissions must meet the following requirements.
- The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor). While the manuscript is undergoing the peer review phase, the authors will not submit the manuscript to another journal without notifying the Editor.
- The submission file is in Microsoft Word, RTF, or PDF document file format.
- We fight plagiarism: please understand that your article will be checked with available tools for discovering plagiarism.
- The text is DOUBLE-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
- Please read this advice and download associated files. The International Committee of Medical Journal Editors has recently published in all ICMJE journals an editorial introducing a new “Disclosure Form for Potential Conflict of Interest”, with the aim to establish uniform reporting system, which can go over the existing differences in current formats or editors’ requests. We at PAGEPress Publications welcome this initiative as a possible uniforming, standardizing way to have this important disclosure authorizing the publications of manuscripts. We are therefore asking you to duly fill in the “Uniform Format for Disclosure of Competing Interests in ICMJE Journals” and upload it on the Web site of the PAGEPress journal your work is involved with or email it back to us, in mind to allow PAGEPress to peer-reviewing your work. The document is in Adobe format, it includes instructions to help authors provide the requested information and the completion procedure is user-friendly. Kindly note that the format have to be completed and signed by each author of the work. We remain waiting for the completed form to proceed with publication. Please be informed that if this Disclosure Form is missing, we will not be able to publish your work.
- Authorship and Contributorship: All persons designated as authors should qualify for authorship according to the ICMJE criteria. Authors must disclose whether they used artificial intelligence (AI)-assisted technologies (such as Large Language Models [LLMs], chatbots, or image creators) in the creation of submitted work. Authors who use such technology must explain how they used it in both the cover letter and the submitted work, and they must guarantee that their paper, including text and images generated by the AI, is free of plagiarism. Changes in Authorship: If authors request removal or addition of an author after manuscript submission or during the peer-review process, the journal editors should receive a letter clearly explaining the reason for the change. Please note that if your manuscript is accepted you will not be able to make any changes to the authors, or order of authors.
- Authors are kindly required to suggest at least two potential reviewers (name, affiliation and e-mail) for their manuscript in the "Comments to the Editor" field (Step 1. Submission Process).
- The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.
Editorials and commentaries
1000 words max, no abstract required, 10 references max. Editorials and commentaries are published at the Editorial Board's discretion. A maximum of two authors are permitted.
Articles
3500 words max, abstract 250 words max, 50 references max, 4/6 tables and/or figures. Original articles present unique observations based on relevant experience in the field of geriatric surgery. Original articles should typically include the following sections: Abstract, Introduction, Materials and Methods, Results, and Discussion.
Reviews
4000 words max, abstract 250 words max, minimum 40 references, 3/5 tables and/or figures. Review articles are papers written by experts on specific topics of general interest. Systematic reviews and meta-analyses are also welcome in this section. The PRISMA guidelines should be followed when conducting a meta-analysis of a randomized trial; a PRISMA flow chart and check list should be included.
Prospective randomized trials
About 2000 words, abstract 150 words max, 20 references max, 3 tables and/or figures. Prospective randomized trials should be registered in a searchable electronic registry. The CONSORT statement guidelines should be followed by all randomized trials.
Letters to the Editor
800 words max, 5 references max, 4 authors max, no abstract required, max 1 table/figure. Letters to the Editors should be addressed to the Editors-in-Chief and formatted as short essays expressing the authors' point of view. They may respond to published manuscripts in our journals, or they may provide information or news about a topic related to the Journal's scope. If the letter is in response to a published manuscript, the original manuscript's authors will be given the opportunity to respond.
Case Reports
About 2000 words, unstructured abstract 150 words max, 20 references max, 3 tables and/or figures max. Reports describing observations on clinical cases that can be educational, including adverse effects of drugs or outcomes of a specific treatment. They should be divided into: Abstract, Introduction, Case report(s), Discussion, Conclusions and References.
A maximum of 10 authors is permitted and additional authors should be listed in an ad hoc Appendix.
Copyright Notice
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Privacy Statement
Privacy & Data Protection
This journal is published and managed by PAGEPress® srl (Pavia, Italy, VAT IT02125780185), which acts as the data controller for all personal data processed through this platform, in compliance with Regulation (EU) 2016/679 (GDPR).
Personal data collected through the editorial system (names, email addresses, affiliations, manuscript data, review records) is processed exclusively for the management of the peer review and publication workflow. We do not sell or share your data with third parties for marketing purposes.
For full details on data categories, legal bases, retention periods, your rights under GDPR, and how to exercise them, please read our complete Privacy Policy. Contact: office@pagepress.org.